Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lactase-phlorizin hydrolase (LPH) is a membrane-bound glycoprotein enzyme primarily found in the brush border of enterocytes in the small intestine. It plays a crucial role in carbohydrate digestion, particularly lactose, and also hydrolyzes certain glycosides such as phlorizin. Deficiency or malfunction results in primary or secondary lactose intolerance due to inability to digest dietary lactose. Polymorphisms leading to persistent expression allow continued milk digestion into adulthood—a trait selected for in some populations. Congenital mutations cause rare but severe forms of neonatal-onset malabsorption syndromes.
LPH hydrolyzes lactose into D-glucose and D-galactose, and also hydrolyzes phlorizin and other β-glycosides.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lactase-phlorizin hydrolase (None).